A functional polymorphism in the promoter region of the cyclooxygenase-2 gene is not associated with asthma and atopy in an Australian population

Clinical and Experimental Allergy

Volumn 34, Issue 11, 2004, Pages 1714-1718

  Shi, J ^a,b   Misso, N L ^a   Duffy, D L ^c   Thompson, Philip J ^a,d   Kedda, M A ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

Aspirin intolerant asthma; Asthma; Atopy; Australian Caucasian population; Cyclooxygenase 2 (COX 2); Promoter polymorphism

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CYCLOOXYGENASE 2; PROSTAGLANDIN E2; SYNAPSIN I;

ADULT; AGED; ALLELE; ARTICLE; ASPIRIN INTOLERANT ASTHMA; ASTHMA; ATOPY; AUSTRALIA; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENETIC TRANSCRIPTION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROSTAGLANDIN RELEASE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; ASTHMA; CYCLOOXYGENASE 2; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SEVERITY OF ILLNESS INDEX;

EID: 9244234422     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2004.02094.x     Document Type: Article

References (31)

1. Tattersfield AE, Knox AJ, Britton JR, Hall IP. Asthma. Lancet 2002; 360:1313-22.
2. Molimard M, Marthan R. Genetic polymorphism and asthma. Rev Mal Respir 2000; 17:564-8.
3. Hakonarson H, Wjst M. Current concepts on the genetics of asthma. Curr Opin Pediatr 2001; 13:262-77.
4. Dubois RN, Abramson SB, Crofford L et al. Cyclooxygenase in biology and disease. FASEB J 1998; 12:1063-73.
5. 2 as a mediator of allergic asthma. Science 2000; 287:2013-7.
6. 2, but not prostacyclin inhibits histamine-induced contraction of human bronchial smooth muscle. Eur J Pharmacol 1995; 272:13-9.
7. 2. Lancet 1995; 345:436-8.
8. 2 on allergen-induced airway responses and airway inflammation. Am J Respir Crit Care Med 1999; 159:31-6.
9. Taha R, Olivenstein R, Utsumi T et al. Prostaglandin H synthase 2 expression in airway cells from patients with asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161:636-40.
10. 2 concentrations and cyclooxygenase-2 expression in asthmatic subjects with sputum eosinophilia. J Allergy Clin Immunol 2003; 112:709-16.
11. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 2003; 111:913-21.
12. Sousa A, Pfister R, Christie PE et al. Enhanced expression of cyclooxygenase isoenzyme 2 (COX-2) in asthmatic airways and its cellular distribution in aspirin-sensitive asthma. Thorax 1997; 52:940-5.
13. Picado C, Fernandez-Morata JC, Juan M et al. Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. Am J Respir Crit Care Med 1999; 160:291-6.
14. Picado C, Bioque G, Roca-Ferrer J et al. Nuclear factor-κB activity is down-regulated in nasal polyps from aspirin-sensitive asthmatics. Allergy 2003; 58:122-6.
15. Vignola AM, Bellia V. Transcriptional regulation of COX-2: a key mechanism in the pathogenesis of nasal polyposis in aspirin-sensitive asthmatics? Allergy 2003; 58:95-7.
16. Papafili A, Hill MR, Brull DJ et al. Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response. Arterioscler Thromb Vasc Biol 2002; 22:1631-6.
17. Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ, Willoughby DA. Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 1999; 5:698-701.
18. National Asthma Council. Asthma management handbook 2002. National Asthma Council Australia Ltd, South Melbourne, 2002.
19. National Institutes of Health. National asthma education and prevention program, expert panel report II: guidelines for the diagnosis and management of asthma 1997, Bethesda, MA. publication no. 97-4051.
20. Kedda MA, Shi J, Duffy DL et al. Characterisation of two polymorphisms in the leukotriene C4 synthase gene in an Australian population of subjects with mild, moderate, and severe asthma. J Allergy Clin Immunol 2004; 113:889-95.
21. Vally H, Taylor ML, Thompson PJ. The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients. Thorax 2002; 57:569-74.
22. Riva A, Kohane IS. SNPper: retrieval and analysis of human SNPs. Bioinformatics 2002; 18:1681-5.
23. Tatusova TA, Madden TL. BLAST2 sequences, a new tool for comparing protein and nucleotide sequences. FEMS Microbiol Lett 1999; 174:247-50.
24. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna. Austria, 2003, ISBN 3-900051-00-3, url = http://www.R-project.org.
25. Xu Q, Ji Y-S, Schmedtje JF Jr. Sp1 increases expression of cyclooxygenase-2 in hypoxic vascular endothelium: implications for the mechanisms of aortic aneurysm and heart failure. J Biol Chem 2000; 275:24583-9.
26. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003; 111:1805-12.
27. Szczeklik W, Sanak M, Szczeklik A. Association of a novel cyclooxygenase-2 gene polymorphism G-765C with bronchial asthma. Proceedings of the XXII European Academy of Allergology and Clinical Immunology. Pharma service GmbH, Paris, 2003.
28. Sanak M, Simon H-U, Szczeklik A. Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet 1997; 350:1599-600.
29. 4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States. J Allergy Clin Immunol 2000; 106:72-6.
30. Choi J-H, Park H-S, Oh H-B et al. Leukotriene-related gene polymorphisms in ASA-intolerant asthma: an association with a haplotype of 5-lipoxygenase. Hum Genet 2004; 114:337-44.
31. Colville-Nash PR, Gilroy DW. Cyclooxygenase enzymes as targets for therapeutic intervention in inflammation. Drug News Perspect 2000; 13:587-97.